Fidelity European Trust: Over 30% NAV and share price 3 year growth

Fidelity

Fidelity European Trust plc (LON:FEV) has published its fact sheet for the period to 31 December 2022.

Portfolio Manager Commentary 

Continental European equities edged lower in December after the European Central Bank (ECB) raised interest rates by 0.5% at its December meeting, bringing the deposit facility rate to 2%. The ECB said that significant rate hikes are expected at a steady pace to ensure that inflation returns to its 2% target. The central bank announced that it would begin to shrink its asset purchase programme portfolio in March by stopping the reinvestment of EUR 15 billion per month of maturing bonds. Solid US economic data led to renewed fears that the ECB may remain hawkish for longer, while a downward revision to the UK’s GDP added to the bearish sentiment. Against this backdrop, all sectors ended the month in negative territory, with IT stocks leading the laggards. From a style perspective, value stocks outperformed their growth counterparts and small-cap names outperformed their large and mid-cap counterparts.

During the month, the Trust’s NAV slightly underperformed the index. The overweight stance in technology and stock selection in financials weighed on returns, although security selection contributed to performance in the health care sector. At a stock level, private equity company Partners Group was a notable detractor amid concerns over high management fees and pressure on assets under management.

On a rolling 12-month basis, the Trust recorded NAV and share price returns of -3.6% and -3.8% respectively, compared to -7.0% for the index.

Fidelity European Trust PLC (LON:FEV) aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.

Share on:
Find more news, interviews, share price & company profile here for:

Investing in Europe: Why investors should remain positive

Co-Portfolio Manager of the Fidelity European Trust PLC (LON:FEV), outlines why he believes quality businesses backed by strong balance sheets and dividend growth potential remain well placed to deliver strong relative returns over the long-term.

Fidelity European Trust rises in August, reporting 16.4% returns in 2025

Fidelity European Trust highlighted strong contributions in August 2025 from KBC Groupe, which upgraded full year guidance, and Novo Nordisk, which advanced on positive trial results and regulatory approval for Wegovy.

Fidelity European Trust Factsheet – July volatility, Legrand and Bankinter gains

Continental European equities were volatile in July, with the Trust underperforming the index due to weak stock selection in financials and healthcare. Novo Nordisk and ASML detracted, while Legrand and Bankinter contributed positively. Over 12 months, the Trust’s NAV rose 1.8% and the share price 1.7%, compared with an 11.3% gain for the index.

European Investment Opportunities – Fidelity’s Quality Focus (LON:FEV)

FEV portfolio manager Marcel Stotzel highlights how quality companies with strong defensive characteristics can help investors navigate uncertainty and achieve long-term growth.

16.7% YTD return hails Fidelity European Trust’s strong credentials

Despite market headwinds, the Trust demonstrated resilience with standout contributions from Legrand and EQT and positive sector positioning. Over the past 12 months, NAV rose 2.3% and share price 5.5%, reflecting our focus on cash‑generative, dividend‑growing companies.

Fidelity European Trust May Factsheet – European equities moved higher

European equities rose in May amid volatility linked to US trade uncertainty. Fidelity European Trust underperformed the index, mainly due to weak positions in consumer sectors.

Search

Search